Arcus Biosciences 주식 가격. RCUS - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

14.62

매수가

매도가

거래량

0.00 일간 변동폭 0.00

13.495 52주 범위 20.31

market_cap

1.338B

전일 종가

14.62

개장가

최근 거래 시간

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

698,351

발행 주식

91,511,609

배당수익률

주가수익률

-4.36

주당순이익(EPS)

-3.35

매출

117M

순이익

-307M

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule... Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies. 더 보기

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.arcusbio.com

본부

Camden, Delaware, USA

설립됨

Arcus Biosciences Inc is listed in the Pharmaceutical Preparations sector of the 뉴욕 증권거래소 with ticker RCUS. The last closing price for Arcus Biosciences was US$14.62. Over the last year, Arcus Biosciences shares have traded in a share price range of US$ 13.495 to US$ 20.31.

Arcus Biosciences currently has 91,511,609 shares in issue. The market capitalisation of Arcus Biosciences is US$1.34 billion. Arcus Biosciences has a price to earnings ratio (PE ratio) of -4.36.

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that...

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Data from the Phase 1/1b ARC-20 study of casdatifan were presented at an oral plenary session at the 2024 EORTC-NCI-AACR Symposium; a low rate of primary progression (19%) and promising...

Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer

Domvanalimab plus zimberelimab was associated with greater progression-free survival, overall survival, and objective response rate compared with those of zimberelimab or chemotherapy A 36...

Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting

Data, including overall survival, from ARC-10, a randomized study evaluating domvanalimab plus zimberelimab in front-line, PD-L1-high, locally advanced or metastatic non-small cell lung cancer...

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...

Form 8-K - Current report

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-1.85	-11.2325440194	16.47	16.47	14.19	599580	15.0704806	CS
4	-3.43	-19.0027700831	18.05	18.98	14.19	842539	16.34549559	CS
12	-2.85	-16.3136805953	17.47	18.98	14.19	698351	16.64812823	CS
26	-2.04	-12.2448979592	16.66	18.98	13.52	701965	16.18559475	CS
52	0.85	6.17283950617	13.77	20.31	13.495	732691	16.62267473	CS
156	-30.91	-67.8893037558	45.53	49.1	12.95	871112	22.29148919	CS
260	6.8	86.9565217391	7.82	49.1	7.645	737931	23.87770657	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PSBDPalmer Square Capital BDC Inc	US$ 22.99 (44.32%)	1
ACRACRES Commercial Realty Corporation	US$ 23.99 (43.31%)	2
SNDASonida Senior Living	US$ 33.00 (38.83%)	3
SDHYPGIM Short Duration High Yield Opportunities Fund	US$ 21.95 (32.63%)	2
SNOWSnowflake Inc	US$ 157.60 (22.06%)	269.11k
AVNSAvanos Medical Inc	US$ 11.01 (-38.39%)	105
SMPStandard Motor Products Inc	US$ 20.00 (-36.67%)	102
CBANColony Bankcorp Inc	US$ 11.12 (-34.47%)	4
SDHCSmith Douglas Homes Corp	US$ 21.00 (-32.78%)	108
WSWorthington Steel Inc	US$ 35.22 (-19.86%)	208
SNOWSnowflake Inc	US$ 157.60 (22.06%)	269.11k
NIONIO Inc	US$ 4.57 (-1.72%)	258.06k
PLTRPalantir Technologies Inc	US$ 61.74 (-0.61%)	228.37k
IONQIonQ Inc	US$ 28.20 (-2.29%)	222.76k
ZETAZeta Global Holdings Corp	US$ 23.45 (1.47%)	183.36k